Centessa Pharmaceuticals Plc(Cnta) Financials: Total Asset Turnover Compared To Industry Average, Plus Other Key Ratios
Growth Trend (Last 5 Years)
Growth - total asset turnover
This chart shows the historical trend of total asset turnover for CNTA compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Total Asset Turnover
Definition: Total asset turnover measures how efficiently the company generates sales from its entire asset base. A high turnover means the company gets a lot of sales out of relatively fewer assets — very efficient. A low turnover may suggest underused assets or bloated balance sheets.
Interpretation:
• In '2022', CNTA's total asset turnover was 0.00, reflecting overall efficiency in utilizing assets. Industry average for Biotechnology: Pharmaceutical Preparations in '2022' stood at 0.15.
• In '2023', CNTA's total asset turnover was 0.02, reflecting overall efficiency in utilizing assets. The increase since '2022' reflects strengthening financial performance. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at 0.17. Industry average increased by 0.01 compared to previous year.
• In '2024', CNTA's total asset turnover was 0.00, reflecting overall efficiency in utilizing assets. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Pharmaceutical Preparations in '2024' stood at 0.20. Industry average increased by 0.03 compared to previous year.
Overall, CNTA's total asset turnover has been volatile but generally stable over the past 3 years.
Formula: Total Asset Turnover = Net Sales / Total Assets
Good Range: Ranges from 0.5 to 2 depending on business type.